Stocks / Technology · Electronic Components
Camtek CAMT
Outside our quality screen, so we don’t track its dips. It’s 48% below its 52-week high.
Outside our quality screen, trading well above our fair value estimate.
Worth knowing
- Down 50% from its 52-week high while revenue grew 16%
From the data on this page, as of the last close. How we pick these
- Fair value est.
- $78.70−27%
- Market Value
- —
- Off 52-wk high
- −48%
- Risk vs market
- Highbeta 2.87
4 bullish · 5 bearish See why
Valuation
What we estimate it's worth, and how it ranks on value vs every stock we cover.
Fair value estimate
How the range is computed
Ten-year free-cash-flow DCF. Same 10-year free-cash-flow model as the base: discount rate 9.5% ±1 point and growth 15.0% ±2 points. Bear = 10.5% and 13.0%; bull = 8.5% and 17.0% (both fade to 3%). A model estimate from public filings, not a forecast of where the price will go.
Price is above even the bull case.
What the price implies To be worth today’s price, CAMT’s free cash flow would need to grow about 21% a year for five years; our estimate uses 15%.
Risk vs market
How risk vs market is measured
One year of daily returns (Oct 31 to Nov 2, 252 sessions). Beta = how much CAMT moved for each 1% move in the S&P 500 (SPY); 1.0 moves with the market. Volatility is the yearly standard deviation of daily returns. Past behavior, not a forecast.
Swings much more than the market, and its own price swings are 5.5× the S&P 500’s.
- Beta vs S&P 500
- 2.87
- Volatility
- 71% vs 13% SPY
- Correlation SPY
- 0.52
- Correlation QQQ
- 0.64
How it ranks
Where CAMT stands vs every one of the 1,996 stocks we cover that has the number. Longer bar = better.
Top quarter on 1 of 5 measures
- Discount to fair value estimate27% · price above our base caseLowest 29%of 1,314
- Free cash flow yield2.4% · free cash flow vs market capLowest 31%of 1,391
- Dividends + buybacks yield0% · cash paid out or used to retire shares, vs market capLowest 1%of 1,836
- Revenue growth, last 12 months+16% · vs the 12 months beforeTop 33%of 1,814
- Operating margin26% · of sales kept as operating profitTop 16%of 1,288
From SEC filings and our fair value estimate model. A ranking, not advice.
Valuation details
DCF $78.70
Assumes 15.0% growth for 5 years (revenue grew 15.6% a year FY22–FY25; capped at 15%), fading to 3%; 9.5% discount rate, 3% terminal growth. FCF base $2.55 a share (fiscal year to Dec 31, 2025), from the 20-F filed Mar 19, 2026.
Fundamentals
The business itself: sales, profits, cash and debt, from SEC filings.
Bull vs bear
Rule-based from the data on this page, strongest first. Not advice.
Top bullish points 4 of 5
ProfitabilityOperating margin widened to 25.8% in FY2025 from 20.7% in FY2023 (SEC filings).
GrowthSales compounded 16% a year from FY2022 to FY2025.
GrowthSales grew 16% to $496M over the last 12 months vs the 12 months before (SEC filings).
ProfitabilityGross margin widened to 50.5% in FY2025 from 46.8% in FY2023 (SEC filings).
Top bearish points 5 of 5
ValuationOur DCF fair value estimate is $78.70, 27% below the price.
ValuationP/E of 106.6× vs a 33.0× median for the 220 Technology companies we cover.
ProfitabilityReturn on equity fell 8 points in two fiscal years, to 8% in FY2025.
QualityDoesn’t pass our quality screen: no cash-flow data.
RiskSwings hard: beta 2.87 vs the S&P 500 and 71% yearly volatility (SPY 13%).
All fundamentals
P/E 106.6 · FCF yield 2.4% · ROE 9%
Valuation
- P/E
- 106.6×Technology median 33.0×
- Price / FCF
- 42.4×
- FCF yield
- 2.4%
- EV / EBITDA
- n/aD&A or debt not tagged in SEC data
- Price / sales
- 10.90×
- Price / book
- 8.77×
- Market cap
- $5.4Bprice × diluted shares
- Enterprise value
- n/anot reported in its SEC filings
Growth
- Revenue, 12 months
- $496M
- Sales growth, 12 months
- +15.6%vs the 12 months before
- Sales growth, 3 yrs
- +15.6%/yrfrom FY2022
- Diluted EPS, 12 months
- $1.04
- EPS growth, last FY
- −57.0%
- Net income, 12 months
- $51M
- Net income growth
- −57%12 months vs before
Profitability
- Gross margin
- 50.5%
- Operating margin
- 25.8%
- Net margin
- 10.2%
- FCF margin
- 25.7%
- Return on equity
- 9%
- Return on invested capital
- n/aoperating income, debt, equity or cash not tagged
Balance sheet
- Cash & short-term inv.
- $257M
- Total debt
- n/anot reported in its SEC filings
- Net cash
- n/acash or debt not tagged in SEC data
- Debt / equity
- n/adebt or equity not tagged in SEC data
- Interest coverage
- n/ainterest expense not tagged in SEC data
Cash flow & returns
- Free cash flow, 12 months
- $127M
- FCF growth, 12 months
- +14%
- Dividend yield
- 0%
- Payout ratio
- 0%
- Buybacks, 12 months
- n/anot reported in its SEC filings
- Share count, 1 year
- n/ano quarterly diluted share count
- Stock-based comp
- $17M
Trailing 12 months to Dec 31, 2025; balance sheet at Dec 31, 2025. From Camtek’s SEC filings. Sparklines show up to six fiscal years. n/a means we don’t hold that number, with the reason. How each is computed.
The business
Sales +2%
- Gross margin51%
- Operating margin22%
- Return on invested capital20%
- Return on equity8%
- Sales growth (latest quarter vs year-ago quarter)+2%
- Net debt / EBITDA−1.3×
Chart & levels
Where the price is vs its key levels and trends.
Key levels
Every level vs today’s $108.25
- Fair value est.base case$78.70−27.3%
- 52-wk lowlowest close, 1 year$94.40−12.8%
- PriceMon Nov 2 close$108.25you are here
- 52-wk highhighest close, 1 year$207.46+91.6%
Momentum & 52-week range
RSI 30 · 5 days −12.2%
Signals
Reversal signal setups, the public ledger and the next earnings date.
Setup & signals
No setup armed
No setup armed, so there’s no trigger or stop to track yet. Reversal signal rules only run on companies that pass our quality screen.
Next report
Nov 4
- DateWed Nov 4, before the open
- Consensus EPS$0.89
- Year-ago EPS$0.72
- QuarterSep/2026
From Nasdaq’s earnings calendar. A report resets Market Value.
CAMT is outside our quality screen
One text when a published rule fires on one of the 332 quality companies we track: the ticker, the price, the stop and a link to the numbers. Nothing else.
Voices & buzz
Who is talking about it, and how it compares with peers.
Who’s talking about it
Notable investors, executives, analysts and public figures on Camtek in the last 48 hours. Headlines as published, each linked. Their words, not ours.
Morgan StanleyAnalyst rating changeAnalyst
Morgan Stanley Downgrades Camtek (CAMT) Citing Valuation Concerns Despite Mid-Term TargetsGuruFocus ·
Checked Nov 3, 1:01 PM ET. Matched by name against a maintained list plus the company’s own executives. Information only, not advice.
Compare with peers
Closest in size in Electronic Components
Information only, not investment advice. Fair value estimates and talking points are rule-based model output from public data and can be wrong; stop levels are reference points, not orders. How every number is computed.